Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A dose effect of IL-7 on thymocyte development.

Nahed El Kassar1, Philip J Lucas, David B Klug

  • 1Experimental Immunology Branch, National Institutes of Health, 10 Center Drive, Bldg 10 Rm 4B36, Bethesda, MD 20892-1360, USA.

Blood
|May 25, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.

Blood·2026
Same author

Associations and trends in recency of hearing tests in the United States.

American journal of otolaryngology·2026
Same author

Cell Cycle Sensing Shapes Human T Cell Fate and Exhaustion Programs.

bioRxiv : the preprint server for biology·2026
Same author

Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis.

Cell·2026
Same author

Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy.

Blood cancer journal·2026
Same author

Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.

Nature biomedical engineering·2026

Interleukin-7 (IL-7) impacts T-cell development differently based on its concentration. Low levels enhance T-cell production by aiding progenitor survival, while high levels impede it, blocking development.

Area of Science:

  • Immunology
  • Developmental Biology
  • Molecular Genetics

Background:

  • Interleukin-7 (IL-7) is crucial for lymphocyte development.
  • Its precise role in early thymocyte development requires further elucidation.
  • Understanding IL-7's dose-dependent effects is critical for immune therapies.

Purpose of the Study:

  • To investigate the in vivo effects of interleukin-7 (IL-7) overexpression on early thymocyte development.
  • To determine the impact of varying IL-7 levels on T-cell progenitor proliferation and survival.
  • To explore the implications of IL-7's dose-dependent effects in a clinical context.

Main Methods:

  • Generation of transgenic mice overexpressing the IL-7 gene under the lck proximal promoter.
  • Assessment of thymocyte development, progenitor proliferation (Ki-67, BrdU incorporation), and cell survival markers (Bcl-2).

Related Experiment Videos

  • Utilized mixed marrow chimeras and in vivo anti-IL-7 monoclonal antibody treatments to validate findings.

    • Main Results:

    • Low IL-7 overexpression (TgA) enhanced alphabeta T-cell development by increasing progenitor survival.
    • High IL-7 overexpression (TgB) led to decreased progenitor proliferation and a block in T-cell development.
    • Bcl-2 was upregulated in T-cell progenitors across all transgenic lines.

    Conclusions:

    • IL-7 exhibits a dose-dependent effect on alphabeta T-cell development in vivo.
    • Low IL-7 levels promote thymocyte progenitor survival, enhancing T-cell production.
    • High IL-7 levels inhibit progenitor proliferation, causing developmental arrest with significant clinical implications.